stopping semaglutide Half of Patients Stop for Weight Loss by 1 Year will you gain weight back

If youve been struggling with weight loss, GLP-1 treatments at Health Meets Wellness in New York, NY, may offer the breakthrough you need

GLP-1 Receptor Agonist Market Size and Trends Forecast: 2026 - 2033 GLP-1 receptor agonist market is estimated to be valued at USD 31.71 Bn in 2026 and is expected to reach USD 72.33 Bn by 2033, exhibiting a compound annual growth rate (CAGR) of 12.5% from 2026 to 2033

Less Common but Serious Side Effects Some less common but more serious GLP-1 side effects are worth being aware of: Pancreatitis (inflammation of the pancreas) Gallbladder problems (including gallstones) Acute kidney injury (usually as a result of severe dehydration from vomiting or diarrhea) Diabetic retinopathy worsening (particularly in patients with rapid improvement in blood sugar control) Hypoglycemia (when combined with other diabetes medications like sulfonylureas or insulin) All GLP-1 medications also carry a warning regarding a theoretical risk of medullary thyroid carcinoma, based on animal studies

Patients should be instructed to rotate injection sites systematically among the abdomen, thigh, and upper arm, avoiding repeated injections in the same location

Major conclusions Since its discovery, GLP-1 has emerged as a pleiotropic hormone with a myriad of metabolic functions that go well beyond its classical identification as an incretin hormone

Symptoms include bloating, abdominal pain, diarrhea, and, notably, sulfur burps